Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that's made with a more conventional technology than today's U.S. options.
“We do have a problem with vaccine uptake that is very serious in the United States," Marks said. "Anything we can do to get people more comfortable to accept these potentially life-saving products is something that we feel we are compelled to do.” Large studies in the U.S., Mexico and Britain found two doses of the Novavax vaccine were safe and about 90% effective at preventing symptomatic COVID-19. One complication: Those studies were done far earlier in the pandemic, well before more contagious coronavirus variants emerged -- including the omicron mutant and its relatives.
And while the trials showed generally people experienced only mild reactions such as injection-site pain or fatigue, the FDA did highlight a possible concern: six cases of heart inflammation, known as myocarditis, found among the 40,000 people who received the vaccine in studies.
WC More poison
ViralNewsNYC
HV BREAKING NEWS THIS JUST IN. SOURCES SAY. ABSOLUTELY NOBODY GIVES A SHIT
LI Interesting 🤨
ViralNewsNYC No. It IS useless. This has always been about money. Never your health.
Does it prevent transmission If not it's useless like the rest
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyThe outside panel of experts will vote on whether the shot should be authorized, after the agency found it effective but flagged a safety concern.
Source: WSJhealth - 🏆 413. / 53 Read more »
FDA advisers meeting on Novavax, a latecomer in COVID-19 vaccine raceA federal advisory committee will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax. From The New York Times.
Source: chicagotribune - 🏆 8. / 91 Read more »
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxDevelopment of the vaccine, from Novavax, a Gaithersburg, Maryland-based company, was started at the same time as others in 2020, but the company struggled to produce its shot in large quantities.
Source: USATODAYhealth - 🏆 706. / 51 Read more »
FDA advisers back Novavax COVID-19 shots as new US optionNovavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
Source: mercnews - 🏆 88. / 68 Read more »
FDA panel greenlights Novavax COVID-19 vaccineFDA's vaccine chief said another choice in the U.S. may entice at least some vaccine holdouts - whatever their reason - to consider rolling up their sleeves. FOX13 Ha… NOPE!!
Source: fox13seattle - 🏆 328. / 59 Read more »
FDA advisers vote to recommend Novavax Covid-19 vaccineAdvisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease. Does it ever stop Interesting how there is no recognition of where it was developed Baylor College of Medicine and give to the world free and unpatented While pfizer and Moderna rape the public and the press don't cover the the side effects of either! we dont trust you we see the lies posted/printed by the media its painfully clear when you look at it going as fa back as 2012 . you cant be trusted and especially since the FDA was yelling because they want to sell the vax not that people need it . the demand is manufactured.
Source: politico - 🏆 381. / 59 Read more »